June 8, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced completion of patient accrual in its Phase 3 REVELATE clinical trial of ¹⁸F-fluciclovine, a

June 7, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), ultrasound-derived fat fraction (UDFF) is strongly associated with MRI proton-density fat fraction (PDFF) and provides high sensitivity for detecting hepatic steatosis.

June 7, 2022 — At the 2022 Society for Imaging Informatics in Medicine (SIIM) Annual Meeting in Kissimmee, Florida from June 9-11, Intelerad Medical Systems will showcase its recently launched Enterprise Imaging and Informatics Suite at Booth #411.

June 3, 2022 — The Association for Medical Imaging Management (AHRA) has announced the newest members of the AHRA Board of Directors.

2022-2023 President-Elect

Becky Allen, MS, CRA

June 2, 2022 — Today, GE Healthcare issued a statement that it expects production capacity from its Shanghai facility to be close to 100% starting Monday, June 6, following the easing of local COVID-19 restrictions. The statement noted that this will enable GE to restabilize our global supply of iodinated contrast media. GE stated that it will continue to work with impacted customers to help them plan several weeks ahead as supply progressively recovers.